BIOSANTE PHARMACEUTICALS INC 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Feb 9, 2004
Insider Transaction Report
Form 4
MORGENSTERN VICTOR A
Director
Transactions
- Exercise of In-Money
Common Stock
2004-02-05$3.00/sh+75,000$225,000→ 431,277 total - Exercise of In-Money
Warrant
2004-02-05$3.00/sh−75,000$225,000→ 0 totalExercise: $3.00From: 1999-05-06Exp: 2004-05-06→ Common Stock (75,000 underlying) - Exercise of In-Money
Warrant
2004-02-05$3.00/sh−25,000$75,000→ 0 total(indirect: By Trust)Exercise: $3.00From: 1999-05-06Exp: 2004-05-06→ Common Stock (25,000 underlying) - Tax Payment
Common Stock
2004-02-05$6.40/sh−35,156$224,998→ 396,121 total - Tax Payment
Common Stock
2004-02-05$6.40/sh−11,719$75,002→ 283,281 total(indirect: By Trust) - Exercise of In-Money
Common Stock
2004-02-05$3.00/sh+25,000$75,000→ 295,000 total(indirect: By Trust)
Holdings
- 0(indirect: see footnote)
Common Stock
- 70,000(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Held by Morningstar Trust to which Mr. Morgenstern's wife is a trustee. Mr. Morgenstern disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F2]Held by Resolute Partners to which Mr. Morgenstern is a managing director.
- [F3]The reporting person no longer has a reportable beneficial interest in 40,500 shares of BioSante Pharmaceuticals common stock owned by his son and included in the reporting person's prior ownership reports.